Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
PEREGRINE PHARMA (NQ: PPHM)
1.580 USD  -0.080 (-4.82%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about PEREGRINE PHARMA
 
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Bio-Wire Equity Surveillance – Closing Bell 5/21/2013
May 21, 2013
Larger pharmaceutical companies generally kept their net gains in a modest range, with companies between $10-200B in market cap seeing gains within the range of +.5-1% while medium sized companies in... Read More
category TLON , PPHM , SCMP , and 5 more.
from Bio-Wire.Com
Mixed Open Ahead Of Apple's Testimony
May 21, 2013
The markets opened mixed with the Dow adding 7 points to 15,342 while Nasdaq slipped 6 points to 3490 ahead of Apple chief executive Tim Cook's testimony before the Senate's Permanent Subcommittee on... Read More
category Market News
from MarketMinute.com Market Updates
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
category RPTP , ACAD , MDXG , and 15 more.
from Bio-Wire.Com
Peregrine Finalizes Phase III Trial Design
May 20, 2013
Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) reached an agreement with the Food and Drug Administration on the design of a Phase III trial for its lung cancer treatment bavituximab. Shares of the... Read More
from MarketMinute.com Stock News
Mixed Open After Records Last Week
May 20, 2013
The markets opened mixed with the Dow slipping 11 points to 15,342 while Nasdaq added 3 points to 3501 as investors took a breather after another record close last week. Read More
category Market News
from MarketMinute.com Market Updates
Peregrine Pharma agrees with FDA on lung cancer trial design
May 20, 2013
May 20 (Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug. Read More
category companyNews
from Reuters: Company News
Peregrine Pharma (PPHM) Pops Higher on Resumption
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353675 for the full story. Read More
from StreetInsider.com News Articles
Peregrine Pharma (PPHM) to resume trading at 9:15am ET
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353656 for the full story. Read More
from StreetInsider.com News Articles
Peregrine Pharma (PPHM), FDA Reach Agreement Over Bavituximab Phase III Design
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353432 for the full story. Read More
from StreetInsider.com News Articles
Peregrine Pharmaceuticals, Inc. (PPHM) halted, news pending
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353414 for the full story. Read More
from StreetInsider.com News Articles
1 Stock to Buy, 1 Stock to Short: Small-Cap Pharma
May 17, 2013
 Read More
category NASDAQ:PPHM , NASDAQ:AGEN
from InvestorPlace - Latest Headlines
StockCall Early Morning Insight into SQNM, PPHM, OPTR, ONXX, and INO
May 16, 2013
from ACCESSWIRE
Hot Stock: Peregrine Pharmaceuticals, Shares Gain 5.3% (PPHM)
May 13, 2013
from Comtex SmarTrend® News Briefs
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
category GALE , NVS , ONXX , and 17 more.
from Bio-Wire.Com
Peregrine Pharma (PPHM) Issues Update on Bavituximab for NSCLC Into Phase III
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8244202 for the full story. Read More
from StreetInsider.com News Articles
Peregrine Pharmaceuticals Hosts Annual Meeting; Highlights Bavituximab's Potential in Solid Tumor Therapy
April 10, 2013
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today highlighted data... Read More
category Press Releases , PPHM , Benzinga , and 2 more.
from Latest Articles from Benzinga.com
24/7 Wall St. Closing Bell — March 13, 2013: Markets Hold On for Small Gains (BA, ORCL, WAG, YUM, EPB, DOLE, COOL, PPHM, EXPR, BFAM, MW, VRA, LODE, SOL, SPPI, VLO, EBAY)
March 13, 2013
DailyFinance.com : U.S. equity markets opened slightly lower this morning following on some poor data on eurozone industrial production, which fell more than expected. Non-farm payrolls fell more than... Read More
category lode , ebay , sol , and 14 more.
from DailyFinance.com
Peregrine Pharmaceuticals, Synergetics Announce Earnings
March 13, 2013
Peregrine Pharmaceuticals (PPHM) announced that it lost $4.9 million, or 4 cents per share, during the quarter ending on January 31. The company lost $11.1 million, or 13 cents per share, in the same... Read More
category Stocks
from Market News Video
StreetInsider.com Pre-Open Movers 03/13: (DRL) (PPHM) (FIG) Higher; (SPPI) (VELT) (EXPR) Lower (more...)
March 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8181102 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com After-Hours Movers 3/12: (PPHM) (KW) (BA) Higher; (SPPI) (TEU) (DOLE) Lower (more...)
March 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8179646 for the full story. Read More
from StreetInsider.com News Articles
After-Hours Buzz: BA, URBN & More
March 12, 2013
Check out which companies are making headlines after the bell Tuesday: Read More
category Peregrine Pharmaceuticals Inc , Economics , tvcodes/tvecon , and 8 more.
from CNBC.com News
Pharmaceuticals (PPHM) to Meet With FDA Regarding Phase III Trial
March 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8178674 for the full story. Read More
from StreetInsider.com News Articles
Peregrine Pharmaceuticals (PPHM) Tops Q3 EPS by 3c
March 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8178611 for the full story. Read More
from StreetInsider.com News Articles
24/7 Wall St. Closing Bell — March 12, 2013: Markets Can't Overcome Low Open (BBY, RSH, P, AAPL TJX, CVI, DMND, FCEL, URBN, BONT, COST, SSI, DOLE, COOL, PPHM, EXPR, TA, GLU, JCP, ZNGA)
March 12, 2013
DailyFinance.com : U.S. equity markets opened lower this morning but never managed to hold a position in positive territory. Despite a significant drop in U.K. industrial production in February, the... Read More
category aapl tjx , rsh , cool , and 16 more.
from DailyFinance.com
Earnings Scheduled For March 12, 2013
March 12, 2013
Costco Wholesale (NASDAQ: COST ) is estimated to report its Q2 earnings at $1.06 per share on revenue of $25.13 billion. Bridgepoint Education (NYSE: BPI ) is projected to report its Q4 earnings at... Read More
category LMIA , Earnings , Benzinga , and 33 more.
from Latest Articles from Benzinga.com
Trading Radar for 03/12: Costco (COST), Bon-Ton (BONT), Majesco (COOL), Velti (VELT) Report
March 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173878 for the full story. Read More
from StreetInsider.com News Articles
Biotech Movers: Peregrine, PharmAthene Climb on Analyst Coverage
March 11, 2013
 Read More
category NASDAQ:OSIR , NYSEAMEX:PIP , NASDAQ:PPHM , and 3 more.
from InvestorPlace - Latest Headlines
Markets Advance With Unemployment Rate At 4-Year Low
March 08, 2013
The markets advanced during the midday with the Dow climbing 46 points to 14,375 as the nation's unemployment rate fell to a four year low. Nasdaq rose 7 points to 3240. Read More
category Market News
from MarketMinute.com Market Updates
Traders Get Bullish on Shares of Peregrine Pharmaceuticals, Shares Up 12.9% (PPHM)
March 08, 2013
from Comtex SmarTrend® News Briefs
George Zavoico Lists 10 Biotech Stocks Poised to Run
March 08, 2013
category Pharmaceuticals
from Trefis
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Random Thoughts: A Signal That Bears Watching
Todd Harrison
2
Random Thoughts: The Chasm Between Stocks and Commodities Continues to Widen
Todd Harrison
3
Apple: Stock Charts Show It May Be Ready for a Reaction Rally
Jason Haver
4
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
5
The 10 Trading Commandments
Todd Harrison

Financial Product Guide